Lantheus Holdings (LNTH) Change in Receivables (2014 - 2026)
Lantheus Holdings (LNTH) reported Change in Receivables of $2.2 million for Q1 2026, down 91.53% year-over-year from $26.4 million in Q1 2025, and up 7.98% quarter-over-quarter from $2.1 million in Q4 2025.
Lantheus Holdings (LNTH) Change in Receivables (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Change in Receivables data on file, last reported at $2.2 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at $2.2 million, down 91.53% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.2 million (down 172.53% YoY), and the FY2025 annual result was $17.9 million, down 52.53% from the prior year.
- Change in Receivables grew to $2.2 million in Q1 2026 per LNTH's latest filing, from $2.1 million in the prior quarter.
- Over five years, Change in Receivables peaked at $85.2 million in Q1 2022 and troughed at -$43.1 million in Q3 2024.
- A 5-year average of $15.0 million and a median of $14.4 million in 2023 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2022 and 2024: Change in Receivables soared 3529.8% in 2022, then tumbled 1187.77% in 2024.
- A 5-year view of Change in Receivables shows it stood at $16.4 million in 2022, then surged by 55.78% to $25.6 million in 2023, then sank by 128.14% to -$7.2 million in 2024, then jumped by 128.7% to $2.1 million in 2025, then rose by 7.98% to $2.2 million in 2026.
- Business Quant data shows LNTH's Change in Receivables at $2.2 million in Q1 2026, $2.1 million in Q4 2025, and -$12.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.23 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 116.25 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 20.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.23 Mn |
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | -12.83 Mn |
| Sep 30, 2025 | -12.83 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 26.36 Mn |
| Mar 31, 2025 | 26.36 Mn |
| Dec 31, 2024 | -7.20 Mn |
| Dec 31, 2024 | -7.20 Mn |
| Sep 30, 2024 | -43.14 Mn |
| Sep 30, 2024 | -43.14 Mn |
| Jun 30, 2024 | 32.59 Mn |
| Jun 30, 2024 | 32.59 Mn |
| Mar 31, 2024 | 55.44 Mn |
| Mar 31, 2024 | 55.44 Mn |
| Dec 31, 2023 | 25.59 Mn |
| Dec 31, 2023 | 25.59 Mn |